Tuberculosis in Kazakhstan: analysis of risk determinants in national surveillance data
Authors:
- Assel TerlikbayevaATAssel Terlikbayeva
- Sabrina HermosillaSHSabrina Hermosilla
- Sandro GaleaSGSandro Galea
- Neil SchlugerNSNeil Schluger
- Saltanat YegeubayevaSYSaltanat Yegeubayeva
- Tleukhan AbildayevTATleukhan Abildayev
- Talgat MuminovTMTalgat Muminov
- Farida AkiyanovaFAFarida Akiyanova
- Laura BartkowiakLBLaura Bartkowiak
- Zhaksybay ZhumadilovZZZhaksybay Zhumadilov
- Almaz SharmanASAlmaz Sharman
- Nabila El-BasselNENabila El-Bassel
Open Access
- 18 October 2012
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 262
Abstract
Development of tuberculosis (TB) is determined by various risk factors and the interactions of temporal and spatial distributions. The aim of this study was to identify the most salient risk factors for TB disease as well as multidrug resistant TB (MDR-TB) at the oblast (provincial) level in Kazakhstan.Keywords
This publication has 18 references indexed in Scilit:
- Exploitation, vulnerability to tuberculosis and access to treatment among Uzbek labor migrants in KazakhstanSocial Science & Medicine, 2012
- Testing the Ratio of Two Poisson RatesBiometrical Journal, 2008
- Selected biological and behavioural risk factors associated with pulmonary tuberculosis.2007
- Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysisThe Lancet, 2006
- Risk factors for multidrug resistant tuberculosis in Europe: a systematic reviewThorax, 2006
- Risk factors for pulmonary tuberculosis in Russia: case-control studyBMJ, 2005
- Risk Factors for Tuberculosis Among Inmates: A Retrospective AnalysisPublic Health Nursing, 2005
- Global Trends in Resistance to Antituberculosis DrugsNew England Journal of Medicine, 2001
- Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazidThe Lancet, 1999
- Risk Factors for Rifampin-monoresistant Tuberculosis: A Case-Control StudyAmerican Journal of Respiratory and Critical Care Medicine, 1999